BridgeMD
Tests treatment safety and results for Lumbar Radiculopathy
Official title Effectiveness of High Intensity Laser Therapy (HILT) in Patients With Chronic Lumbar Radiculopathy Due to Disc Herniation.
ClinicalTrials.gov ID: NCT06651775
What this study is testing
- What it's testing
- The aim of the researchers in this intervention study was to see the effects of High Intensity Laser Therapy (HILT) on participants' disability, functionality and pain parameters in chronic radicular low back pain due to lumbar disc herniation, and to investigate its superiority over widely used conventional electrotherapy modalities. The main question it aims to answer is: What is the short and long term effect of high intensity laser therapy on low back and leg pain in patients with chronic lumbar radiculopathy due to disc herniation?
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Patients diagnosed with lumbar radiculopathy due to lumbar disc herniation and whose complaints are correlated with lumbar MRI
- Patients aged 18-65 years
- Patients who agreed to participate in the study
- Literate patients
You likely can't join if
- Pregnancy
- Patients with cardiac pacemakers
- Patients with a diagnosis of inflammatory rheumatic disease,
- Patients with a diagnosis of polyneuropathy that precludes receiving treatment,
- Patients with active or history of malignancy within the last 1 year and currently receiving chemotherapy and/or radiotherapy,
- Patients with serious psychiatric illness,
See the full eligibility criteria
- Patients diagnosed with lumbar radiculopathy due to lumbar disc herniation and whose complaints are correlated with lumbar MRI
- Patients aged 18-65 years
- Patients who agreed to participate in the study
- Literate patients
- Pregnancy
- Patients with cardiac pacemakers
- Patients with a diagnosis of inflammatory rheumatic disease,
- Patients with a diagnosis of polyneuropathy that precludes receiving treatment,
- Patients with active or history of malignancy within the last 1 year and currently receiving chemotherapy and/or radiotherapy,
- Patients with serious psychiatric illness,
- Patients with severe coagulation disorders,
- Spinal Stenosis (patients with spinal canal diameter less than 8 mm)
- Patients with neurologic deficits that prevent them from receiving treatment,
- Patients with active infection,
- Patients with vasculitis,
- Patients with skin disease in the treated area,
- Patients who received steroid injections and/or physical therapy for the lumbar region within the last 3 months,
- Patients undergoing lumbar spine surgery,
- Patients with acute trauma,
- Patients with a history of lumbar instability,
- Patients with uncontrolled or severe cardiovascular or metabolic disorders
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Cankaya, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Cankaya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.